Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $21.63 Analyst target: $45.62 Upside: 110.91%
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology and other indications in North America and internationally.
See the full interactive analysis & chart →Informational only — not investment advice.